These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10345496)

  • 21. [Celecoxib].
    Fux R; Mörike K; Gleiter CH
    Dtsch Med Wochenschr; 2002 Apr; 127(15):803-4. PubMed ID: 11951138
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
    Gibofsky A
    J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered].
    MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma.
    Marks F; Harrell K; Fischer R
    South Med J; 2001 Feb; 94(2):256-7. PubMed ID: 11235048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COX-2 inhibitors: no pain, no heart gain?
    Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
    [No Abstract]   [Full Text] [Related]  

  • 26. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy with COX-2 inhibitors. Less risk--better tolerance].
    MMW Fortschr Med; 2000 Dec; 142(49-50):65-6. PubMed ID: 11190944
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA panel rules COX-2 pain drugs should remain on the market.
    Health News; 2005 Apr; 11(4):2. PubMed ID: 15818760
    [No Abstract]   [Full Text] [Related]  

  • 29. Are rofecoxib and celecoxib safer NSAIDS?
    Drug Ther Bull; 2000 Nov; 38(11):81-6. PubMed ID: 11138599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug safety. FDA panel urges caution on many anti-inflammatory drugs.
    Couzin J
    Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414
    [No Abstract]   [Full Text] [Related]  

  • 31. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
    Oliw E; Wollheim FA
    Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
    [No Abstract]   [Full Text] [Related]  

  • 32. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex).
    Wynn RL
    Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547
    [No Abstract]   [Full Text] [Related]  

  • 33. [New indication for selective COX-2 inhibitors. Now also approve for acute pain].
    MMW Fortschr Med; 2002 Mar; 144(10):62. PubMed ID: 11928272
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cyclooxygenase-2 inhibitors in postoperative pain management].
    Güneş Y; Işik G
    Agri; 2004 Jul; 16(3):7-16. PubMed ID: 15382000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain relief at a price. A blow to the heart?
    Comarow A
    US News World Rep; 2001 Sep; 131(8):45. PubMed ID: 11550395
    [No Abstract]   [Full Text] [Related]  

  • 36. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain].
    Nasonova VA
    Ter Arkh; 2001; 73(5):56-7. PubMed ID: 11517752
    [No Abstract]   [Full Text] [Related]  

  • 37. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [COX-2 inhibitor non-steroidal anti-inflammatory drugs, myth or reality?].
    Peretz A
    Rev Med Brux; 2001 Sep; 22(4):A377-80. PubMed ID: 11680204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence with COX-2 inhibitors in managed care: an analysis of claims data.
    Harley C; Wagner S
    Manag Care Interface; 2003 Oct; 16(10):38-45. PubMed ID: 14606259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why don't we initiate more large simple randomized controlled trials?
    Wright JM
    CMAJ; 2003 Nov; 169(11):1170-1. PubMed ID: 14638653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.